Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
CA 02205892 1997-07-21
TYT-E092
- 1 -
MUTANT PRENYL DIPHOSPHATE SYNTHASE
BACKGROUND OF INVENTION
1. Field of Invention
The present invention relates to novel mutant
enzymes which synthesize linear prenyl diphosphates that
are precursors of compounds; important to organisms, such
as steroids, ubiquinones, dolichols, carotenoids,
prenylated proteins, animal hormones, plant hormones, and
the like, or a gene thereof etc.
2. Related Art
Of the substances having important functions in
the body, many substances are biosynthesized using
isoprene (2-methyl-1,3-butadiene) as a building block.
These compounds are called isoprenoids, terpenoids, or
terpenes, and are classified depending on the number of
carbon atoms into hemiterpenes (C5), monoterpenes (C10),
sesquiterpenes (C15), diterpenes (C20), sesterterpenes
(C25), triterpenes (C30), tetraterpenes (C40), and the
like. The actual synthesis starts with the mevalonate
pathway through which mevalonic acid-5-diphosphate is
synthesized, followed by the synthesis of isopentenyl
diphosphate (IPP) which is an active isoprene unit.
The identity of the isoprene unit that was
proposed as an speculated precursor was found to be IPP,
the so-called active isoprene unit. Dimethylallyl
diphosphate (DMAPP), an isomer of IPP, being used as a
substrate in the reaction of isopentenyl adenine, which
is known as a cytokinin and is one of the plant hormones,
is also known to undergo condensation reaction with IPP
to synthesize linear active isoprenoids such as geranyl
diphosphate (GP), neryl diphosphate, farnesyl diphosphate
(FPP), geranylgeranyl diphosphate (GGPP), geranylfarnesyl
diphosphate (GFPP), hexaprenyl diphosphate (HexPP),
heptaprenyl diphosphate (HepPP), and the like.
There are Z-type and E-type condensation
CA 02205892 1997-07-21
- 2 -
w reactions. GPP is a product of E_-type condensation and
neryl diphosphate is a product of Z_-type condensation.
Although, the all-E-type is considered to be the active
form in FPP and GGPP, the Z-type condensation reactions
lead to the synthesis of various polyprenols found in
natural rubber, dolichols, bactoprenols (undecaprenols),
and plants. They are believed to undergo the
condensation reaction using the phosphate ester bond
energy of the pyrophosphate and/or the carbon backbone
present in the molecule to produce pyrophosphate and/or
phosphate as the byproduct of the reaction.
FPP or GGPP serves as a reaction substrate
leading to the synthesis of prenylated proteins (from FPP
or GGPP) represented by G-proteins that are important in
the mechanism of signal transduction in the cell; cell
membrane lipids (from GGPP) of~Iarchaea; squalene (from
FPP) which is a precursor of steroids; and phytoene (from
GGPP) which is a precursor of carotenoid. Prenyl
diphosphates from HexPP and HepPP having six and seven
isoprene units respectively to prenyl diphosphates having
ten isoprene units serve as the precursor of synthesis of
ubiquinone and menaquinone (vitamin K2) that work in the
electron transport system.
Furthermore, via the biosynthesis of these
active-form isoprenoids, the following planty kinds of
compounds that are vital to life have been synthesized.
Just to mention a few, there are plant hormones of
cytokinins and isopetenyl adenosine-modified tRNA that
use hemiterpenes as their precursor for synthesis,
monoterpene geraniol and the nerol isomers thereof that
are the main components of rose oil perfume, and a
camphor tree extract camphor which is an insecticide.
Sesquiterpens include juvenile hormones of insects,
_ diterpenes include a plant hormone gibberellin, trail
pheromones of insects, and retinols and retinals that
function as the visual pigment precursors, binding
components of the purple membrane proteins of halophilic
CA 02205892 1997-07-21
- 3 -.
archaea, and vitamin A.
Furthermore, using squalene, a triterpene, a
variety of steroid compounds have been synthesized,
including, for example, animal sex hormones, vitamin D,
ecdysone which is an mating hormone of insects, a plant
hormone brassinolide, and components of plasma membranes.
Various carotenoids of tetraterpenes that are precursors
of various pigments of organisms and vitamin A are also
important compounds derived from active isoprenoids.
Compounds such as hlorophyll, pheophytin, tocopherol
(vitamin E), and phylloquinone (vitamin K1) are also
derived from tetraterpenes.
The~active isoprenoid synthases that
consecutively condense IPP with such allylic substrates
DMAPP, GPP, FPP, GGPP, GFPP, and the like are called
..
prenyl diphosphate synthases, and are also named, based
on the maximum chain length of the major reaction
products, for example farnesyl diphosphate synthase (FPP
synthase), geranylgeranyl diphosphate (GGPP synthase),
and the like. There are reports on purification,
activity measurement, gene cloning, and its nucleotide
sequencing of enzymes such as farnesyl diphosphate
synthase, geranylgeranyl diphosphate synthase, hexaprenyl
diphosphate synthase, heptaprenyl diphosphate synthase,
octaprenyl diphosphate synthase, nonaprenyl diphosphate
synthase (solanesyl diphosphate synthase), undecaprenyl
diphosphate synthase, and the like from bacteria,
archaea, fungi, plants, and animals.
These active isoprenoid synthases constituting
the basis of synthesis of a great variety of compounds
that are important both in the industry and in the field
of life sciences have attracted little attention
regarding their ind~.strial applications due to their
_ unstable character and low-specific activities. However,
with the isolation of the genes of FPP synthase and GGPP
synthase from thermophilic bacteria and archaea [A. Chen
and D. Poulter (1993) J. Biol. Chem. 268: 11002-11007, T.
CA 02205892 1997-07-21
- 4 -
- Koyama et al.. (1993) J. Biochem. 113: 355-363, S. -i,
Ohnuma et al. (1994) J. Biol. Chem. 269:.14792-14797),
their availability as enzymes has increased.
The enzymes that synthesize prenyl diphosphates
having 20 to 25 carbons are homodimers and are relatively
easy to be reacted in vitro, as have been published in
many reports. However, the enzymes that synthesize
prenyl diphosphates having chain lengths exceeding the
above-mentioned length are believed to be heterodimers,
or to require additional factors such as a lipid, and the
like. Therefore, in order to realize industrial
application thereof, it was necessary to find optimal
conditions that permit reassembly of two kinds of
subunits or additional factors, which was a difficult
task.
Therefore, there has~been a need for the
technology that enables to make the homodimer-type
thermostable prenyl diphosphate synthases capable of
synthesizing prenyl diphosphates having a longer chain
length, by artificially altering the amino acid sequence
of the homodimer type prenyl diphosphate synthases that
are stable and have high specific activity derived from a
thermophilic organism.
As for the prenyl diphosphate synthases derived
from thermophilic organisms, there are at present
examples of the altered FPP synthase derived from
Bacillus stearothermophilus and GGPP synthase derived
from Sulfolobus acidocaldarius. The mutant enzyme of FPP
synthase of Bacillus stearothermophilus and the gene
thereof were selected based on the color change of the
organism by lycopene produced by coexistence of crtB (the
gene of phytoene synthase) and crtI (the gene of phytoene
desaturase, cis:tra.ns isomerase) derived from Erwinia
uredovora and the gene of FPP synthase of the mutant B.
. stearothermophilus in Escherichia coli. GGPP synthase
and its mutant and the gene thereof of S. acidocaldarius
were selected based on the activity of complementing the
CA 02205892 1997-07-21
- 5 -
--glycerol metabolic activity of the HexPP
synthase-deficient budding yeast of Saccharomyces
cereviceae.
The coexistence method of the CrtB and CrtI
genes of E. uredovora cannot be used for screening the
reaction products longer than GGPP of the mutant enzyme,
and the screening method using the complementation
activity of the HexPP synthase-deficient budding yeast
Saccharomyces cereviceae cannot be used for specific
detection of the reaction products longer than HexPP.
These genetic screening methods are capable of cloning
the genes of the mutant prenyl diphosphate synthases
having the synthetic activities of GGPP, GFPP, and HexPP,
but cannot systematically control the chain length of the
reaction products of prenyl;diphosphate synthases with
the intention of extending the~chain length of the
reaction products. A rule for that purpose is not known,
either.
SUMMARY OF INVENTION
It is an object of the invention to establish a rule
for systematic control of the chain length of reaction
products by modifying amino acid residues of prenyl
diphosphate enzymes. A new enzyme that is more stable or
that has a high specific activity more adaptable to
industrial application would make it possible to obtain
immediately a mutant enzyme or the gene thereof that
synthesizes prenyl diphosphate having a longer chain
length by modifying amino acid residues based on the
above rule.
From the information on the nucleotide sequence of
the gene of GGPP synthase of the mutant S.
acidocaldarius, 'it was clarified that out of the two
proposed Asp-rich domains based on the analysis of the
amino acid sequence of prenyl diphosphate synthase, the
. amino acid residue located at the fifth position upstream
of the Asp-rich domain conserved sequence I (DDXX(XX)D)
at the amino terminal side is involved in the control of
CA 02205892 1997-07-21
- 6 -
the chain length of reaction products.
Therefore, the present invention provides a mutant
prenyl diphosphate synthase wherein an amino acid residue
located at the fifth position in the N-terminal direction
from D of the N-terminal of the Asp-rich domain DDXX(XX)D
(the two X's in the parentheses may not be present)
present in the second region of the conserved regions of
the original prenyl diphosph-ate synthase has been
substituted by another amino acid.
The present invention also provides a DNA or an RNA
encoding said enzyme..
The present invention further provides a recombinant
vector comprising said DNA, specifically an expression
vector.
The present invention,further provides a host
transformed by the above vector.
The present invention further provides a method for
producing prenyl diphosphates having 20 carbons or more
characterized in that the above enzyme is contacted with
a substrate selected from the group consisting of
isopentenyl diphosphate, dimethylallyl diphosphate,
geranyl-diphosphate, farnesyl diphosphate, and
geranylgeranyl diphosphate.
The present invention further provides a'method for
producing the enzyme as set forth in any of claims 1 to
4, said method comprising culturing the above-mentioned
host and then harvesting the expression product from the
culture.
BRIEF EXPLANATION OF THE DRAWINGS
Fig. 1 is a graph showing the enzymatic activity of
the 19 mutant type BstFPSs (B. stearothermophilus FPP
synthase) obtained and a wild type BstFPS (sample name
Y). "primer: DMAPP'_ indicates that DMAPP was used as the
allylic substrate, "primer:- GPP" indicates that GPP was
. used as the allylic substrate, and "primer: FPP"
indicates that FPP.was used as the allylic substrate. In
the samples named A to W, the name of amino acid after
CA 02205892 1997-07-21
- ~ introduction of substitution at position 81 is indicated
by a one-letter code.
Fig. 2 shows a photograph of a development pattern
of TLC of the dephosphorylated product of the mutant
BstFPSs' reaction when DMAPP was used as the allylic
substrate. Y81A to Y81Y represent amino acid
substitution mutations.
Fig. 3 shows a Photograph of a development pattern
of TLC of the dephosphorylated product of the mutant
BstFPSs' reaction when GPP was used as the allylic
substrate. Y81A to~Y8lY represent amino acid
substitution mutations.
Fig. 4 shows a photograph of a development pattern
of TLC of the dephosphorylated product of the mutant
BstFPSs' reaction when EPP was used as the allylic
- , ,
substrate. Y81A to Y81Y represent amino acid
substitution mutations.
Fig. 5 is a graph showing the relationship between
the enzymatic activity when DMAPP was used as the allylic
substrate and the molecular weights of the amino acid
side chains.
Fig. 6 is a graph showing the relationship between
the enzymatic activity when GPP was used as the allylic
substrate and the molecular weights of the amino acid
side chains.
Fig. 7 is a graph showing the relationship between
the enzymatic activity when PPP was used as the allylic
substrate and the molecular weights of the amino acid
side chains.
Fig. 8 is a graph showing the relationship between
average chain length of the reaction products when DAMPP
was used as the allylic substrate and the molecular
weights of the amin.o_acid side chains.
Fig. 9 is a graph showing the relationship between
average chain length of the reaction products when PPP
was used as the allylic substrate and the molecular
weights of the amino acid side chains.
CA 02205892 1997-07-21
_ g _
Fig. 10 is a graph showing the relationship between
average chain length of the reaction products when FPP
was used as the allylic substrate and the molecular
weights of the amino acid side chains.
Fig. 11 is a graph showing the regions (I) to (VII)
of various prenyl diphosphate synthases and Asp-rich
domains, and the amino acid (asterisk) positioned at the
fifth position in the N-terminal direction from the end
thereof. In the figure, the sequence represents the
amino acid sequence of farnesyl diphosphate synthase, 1
is the one derived from Bacillus stearothermo~hilus, 2
from Escherichia coli, 3 from Saccharomyces cereviceae, 4
from a rat, and 5 from a human.
DETAILED DESCRIPTION
It has been proposed that there are seven conserved
regions in the amino acid sequences of prenyl diphosphate
synthase (one subunit in the case of a heterodimer) (A.
Chem et al., Protine Science Vol. 3, pp. 600-607, 1990 .
It is also known that of the five conserved regions, the
region II containing an Asp-rich domain conserved region
I [DDXX(XX)D] (the two X's in the parentheses may not be
present). Although there is also an Asp-rich domain in
region IV, the Asp-rich domain used to specify the
modified region of the amino acid sequence of the present
invention is present in region II, said domain being
termed as the aspartic acid-rich domain I as compared to
the aspartic acid-rich domain II present in region VI.
As to the prenyl diphosphate synthases having the
Asp-rich domain as described above, there can be
mentioned farnesyl diphosphate synthase, geranylgeranyl
diphosphate synthase, hexaprenyl diphosphate synthase,
heptaprenyl diphosphate synthase, octaprenyl diphosphate
synthase, nonapreny.l_ diphosphate synthase, undecaprenyl
_ diphosphate synthase, and the like. More specific
examples include farnesyl diphosphate synthase of
Bacillus stearothermophilus, farnesyl diphosphate
synthase of Escherichia coli, farnesyl diphosphate
CA 02205892 1997-07-21
_ g _
w synthase of Saccharomyces cereviceae, farnesyl
diphosphate synthase of the rat, farnesyl diphosphate
synthase of the human, geranylgeranyl diphosphate
synthase of Neurvspora crassa, hexprenyl diphosphate
synthase of Saccharomyces cereviceae, and the like.
By way of example of some of these, regions I to
VII and the Asp-rich domain I (in the box) in region II
of the amino acid sequence o~f farnesyl diphosphate
synthases are shown in Fig. 11.
The present invention can be applicable to the
prenyl diphosphate synthases having these aspartic
acid-rich domains I.
According to the present invention, the amino acid
residue located at the fifth position in the N-terminal
direction from the amino acid D of the N-terminal of the
amino acid sequence constituting said Asp-rich domain I
"DDXX(XX)D" (the two X's in the parentheses may not be
present) is substituted by another amino acid. This
amino acid is indicated by an asterisk in Fig. 11. The
amino acid after substitution may be any naturally
occurring amino acid other than the original amino acid.
As one such example there is mentioned an enzyme having
the amino acid sequence in which amino acid tyrosine at
the position 81 in SEQ ID No: 1 has been substituted by a
naturally occurring amino acid.
Many mutant prenyl diphosphate synthases of the
present invention can synthesize a prenyl diphosphate
having a longer chain length than that synthesized by the
native prenyl diphosphate synthase. For example, some of
the farnesyl diphosphate synthases that can synthesize a
farnesyl diphosphate having 15 carbons, when modified
into a mutant enzyme, can synthesize hexaprenyl
diphosphate having,30 carbons.
_ It is known that an enzyme may retain its original
enzymatic activity even~when its original amino acid
sequence is modified by addition, deletion, and/or
substitution of one or a few amino acids. Therefore, the
CA 02205892 1997-07-21
- 10 -
present invention is intended to encompass, in addition
to the peptides having the amino acid sequence as set
forth in SEQ ID No: 1, those enzymes that contain amino
acid sequences modified by substitution, deletion, and/or
addition of one or a few, for example up to 5, or up to
10, amino acids, and that can perform its original
function.
The present invention also provides the genes
encoding various above-mentioned mutant enzymes, the
vectors containing those genes, specifically expression
vectors, and the hosts transformed with said vectors.
The gene (DNA) of the present invention can be readily
obtained, for~example, by introducing mutation into the
DNA encoding the native amino acid sequence as set forth
in SEQ ID No: 1 using site-specific mutagenesis or other
.. ,
conventional methods such as PCR and the like.
Furthermore, once the amino acid sequence of the
desired enzyme has been determined, an appropriate
nucleotide sequence thereof can be determined and the DNA
can be chemically synthesized in accordance with a
conventional method of DNA synthesis.
The present invention further provides an expression
vector comprising DNA such as the one mentioned above,
the host transformed with said expression vector, and a
method for producing the enzyme or peptide of the present
invention using these hosts.
Expression vectors contain an origin of replication,
expression regulatory sequences etc., but they may differ
with the hosts. As to the hosts, there can.be mentioned
procaryotes, for example, bacteria such as Escherichia
coli, and genus Bacillus such as Bacillus subtilis, as
well as eucaryotes, for example, fungi such as yeast, for
example genus Saccharomyces, such as Saccharom~ces
- cereviceae, genus Pichia such as Pichia pastoris,
filamentous fungi, for example genus Asperaillus such as
Asperaillus oryzae and Asperaillus niQer, animal cells,
for example the cultured cell of the silkworm, cultured
CA 02205892 1997-07-21
- 11 -
cells of higher animals such as CHO cell, and the like.
Furthermore, plants may be used as the host.
As shown in Examples, in accordance with the present
invention during culturing the host transformed by the
DNA of the present invention, long-chain prenyl
diphosphates such as GGPP, GFPP, Hexpp, and the like may
be accumulated in the culture medium, which may be
recovered to produce their -respective diphosphates..
Furthermore, in accordance with the invention, long-chain
prenyl diphosphates may also be produced by bringing the
mutant prenyl diphosphate synthase produced in accordance
with the invention in contact with a substrate
isopentenyl diphosphate and allyl substrate such as
farnesyl diphosphate.
When Escherichia coli is used as the host, it is
known that the host has the regulatory functions of the
gene at the stage of transcribing mRNA from DNA and of
translating protein from mRNA. As the promoter sequence
regulating mRNA synthesis, there are known, in addition
to the naturally occurring sequences (for example, lac,
trp, bla, lpp, PL, PR, ter, T3, T7, etc.), their mutants
(for example, lacUV5), and the sequences (such as tac,
trc, etc.) in which a naturally occurring promoter is
artificially fused, and they can be used for the present
invention.
It is known that the distance between the sequence
of the ribosome biding site (GAGG and similar sequences
thereof) and the initiation codon ATG is important as the
sequence regulating the ability of synthesizing protein
from mRNA. It is also well known that a terminator (for
example, a vector containing rrnPTl T2 commercially
available from Pharmacia) that directs completion of
transcription termination at the 3'-end affects the
efficiency of protein synthesis by a recombinant.
As to the vectors that can be used for preparation
of the recombinant vectors of the present invention,
CA 02205892 2000-06-13
- 12 -
various vectors may be mentioned that are derived
depending on the intended use. For example, there can be
mentioned pBR322, pBR327, pKK223-3, pKK233-3, pTrc99, and
the like having a replicon derived from pMBl; pUCl8,
pUCl9, pUC118, pUC119, pTV118N, pTV119N, pBluescript,
pHSG298, pHSG396, and the like that have been altered to
enhance copy numbers; or pACYC177, pACYC184, and the like
that have a replicon derived from plSA; and, furthermore,
plasmids derived from pSC101, ColEl, R1, F factor, and
the like. Furthermore, fusion protein-expressing vectors
that enable easier purification such as pGEX-2T, pGEX-3X,
pMal-c2 may be used. One example of the gene used as the
starting material of the present invention is described
in Japanese patent application No. 6-315572.
Furthermore, in addition to,plasmids, virus vectors
such as ~1 phage or M13 phage, or transposon may be used
for introduction of genes. With regard to the
introduction of the gene into microorganisms other than
Escherichia coli, gene introduction into organisms of
genus Bacillus by pHY300PLK (Takara Shuzo) is known.
These vectors are described in Molecular Cloning (J.
Sambrook, E.F. Fritsch, and T. Maniatis, Cold Spring
Harbor Laboratory Press, 1989) and Cloning Vector (P. H.
Pouwels, B.E. Enger, Valk, and W.J. Brammar, Elsevier),
and catalogues of many manufacturers.
pTrc99is particularly preferable since it has, in
addition to a selectable marker of the ampicillin
resistant gene, a promoter, regulatory genes such as Ptrc
and lacIq, the sequence AGGA as the ribosome binding
site, rrnPTlT2 as the terminator, and the function of
regulating expression of the gene of FPP synthase.
Integration of the DNA fragment encoding the prenyl
diphosphate synthase and, where needed, the DNA fragment
. having the function of regulating expression of the gene
of said enzyme into these vectors can be performed by a
known method using an appropriate restriction enzyme and
CA 02205892 2000-06-13
- 13 -
ligase. Specific examples of the plasmids thus
constructed include, for example, pTV118N-Bst FPS.
As the microorganisms used for integration of genes
by such recombinant vectors, Escherichia coli and
microorganisms of the genus Bacillus may be used. Such a
transformation can also be carried out using the CaClZ
method and the protoplast method as described in
Molecular Cloning (J. Sambrook, E.F. Fritsch, and T.
Maniatis, Cold Spring Harbor Laboratory Press, 1989) and DNA
Cloning Vol. I to III (D. M. Clover ed., IRL PRESS).
In order to produce the mutant enzyme of the present
invention, a host transformed as above is cultured, and
then said culture is subjected to any method comprising
salting out, precipitation with an organic solvent, gel
chromatography, affinity chromatography, hydrophobic
interaction chromatography, ion exchange chromatography,
and the like to recover and purify said enzyme.
The present invention also provides a process for
producing prenyl diphosphates using the enzyme of the
present invention. According to this method, the enzyme
of the present invention is reacted in a medium,
particularly an aqueous medium, and then, as desired, the
prenyl diphosphate is recovered from the reaction medium.
As the enzyme, not only a purified enzyme but also a
crude enzyme that may be semi-purified to various stages,
or a mixture of the cultured biomass of a microorganism
may be used. Alternatively there may be used immobilized
enzymes prepared according to the conventional method
from said enzyme, crude enzyme, or product containing the
enzyme.
As the substrate, there may be used prenyl
diphosphates and isopentenyl diphosphates having 5 to 20,
preferably 5, carbons fewer than the number of carbons of
. the desired prenyl diphosphate. As the reaction medium,
water or an aqueous buffer solution, for example Tris
buffer or phosphate buffer and the like, may be used.
CA 02205892 1997-07-21
- 14 -
By using the system of regulating chain length of
the reaction product of prenyl diphosphate synthase
obtained by the present invention, the prenyl diphosphate
having longer chain length, synthesis of which has so far
been possible only with the hetero-dimer type enzyme, can
be synthesized using mutant prenyl diphosphate synthase
of the homo-dimer type that is easier to handle.
Furthermore, by modifying the amino acid residue located
five amino acids upstream of the aspartic acid-rich
domain I of the corresponding subunit having the aspartic
acid-rich domain of the hetero-dimer type prenyl
diphosphate synthase using the above system, creation of
the mutant enzyme that synthesizes prenyl diphosphates
having further longer chains can be expected.
In the claims and the specification of the present
,. , ,
invention, amino acid residues are expressed by the
one-letter codes or three-letter codes:
A; Ala; alanine
C; Cys; cystine
D; Asp; aspartic acid
E; Glu; glutamic acid
F; Phe; phenylalanine
G; Gly; glycine
H; His; histidine
I; Ile; isoleucine
K; Lys; lysine
L; Leu; leucine
M; Met; methionine
N; Asn; asparagine
P; Prl; proline
Q; Gln; glutamine
R; Arg; arginine
S; Ser; serine
T; Thr; threonine -
V; Val; valine
W; Trp; tryptophan
Y; Tyr; tyrosine
CA 02205892 1997-07-21
- 15 -
Substitution of amino acid is expressed in the order
of "the amino acid residue before substitution," "the
number of the amino acid residue," and "the amino acid
residue after substitution." For example, the mutation
in which a tyrosine residue at position 81 is replaced
with a methionine residue is expressed as Y81M.
EXAMPLES
The present invention -is now explained with
reference to specific examples, but they must not be
construed to limit the invention in any way.
Example l: Construction of a plasmid containina the
Gene of FPP synthase
The gene. of FPP synthase (hereinafter referred to as
BstFPS) derived from Bacillus stearothermophilus was
subcloned at the NcoI-HindIII site of the plasmid vector
.. , ,
pTV118N commercially available from Takara Shuzo. The
plasmid DNA was designated as pTV118N-BstFPS. The BstFPS
gene is available from Escherichia coli JM109 (pEXl) that
was internationally deposited on September 26, 1991 with
the National Institute of Bioscience and Human-
Technology, Agency of Industrial Science and Technology,
of Ibalaki, Japan under the accession number of FERM
BP-3581. Also, the entire nucleotide sequence of the
BstFPS gene has been published in Japanese patent
application 3(1991)-253788, T. Koyama et al., (1993) J.
Biochem. 113:355-363, or in the genetic information data
bank such as GenBank under the accession number D13293.
Since Bacillus stearothermophilus is also available from
various depositories of microorganisms such as ATCC etc.,
the DNA of the gene of BstFPS region can be obtained by
the conventional gene cloning method.
Example 2: Synthesis of the oliaonucleotides for
introducing mutation
- For introduction of mutation of the gene of FPP
synthase, the following oligonucleotides were designed
and synthesized:
Primer DNA (Y81X): 5'GAT CCA TAC GNN NTC TTT GAT TCA
CA 02205892 1997-07-21
- 16 -
TGA TGA TTT G3' (SEQ ID No: 2)
Primer DNA (Y81N): 5'GAT CCA TAC GAA CTC TTT GAT TCA
TGA TGA TTT G3' (SEQ ID No: 3)
Primer DNA (Y81I): 5'GAT CCA TAC GAT TTC TTT GAT TCA
TGA TGA TTT G3' (SEQ ID No: 4)
Primer DNA (Y81M): 5'GAT CCA TAC GAT GTC TTT GAT TCA
TGA TGA TTT G3' (SEQ ID No: 5)
Primer DNA (Y81F): 5'GAT CCA TAC GTT CTC TTT GAT TCA
TGA TGA TTT G3' (SEQ ID No: 6)
Primer DNA (YS1P): 5'GAT CCA TAC GCC GTC TTT GAT TCA
TGA TGA TTT G3' (SEQ ID No: 7)
Primer DNA (Y81V): 5'GAT CCA TAC GGT GTC TTT GAT TCA
TGA TGA TTT G3' (SEQ ID No: 8)
They are designed to newly introduce the cleavage
site of the restriction enzyme BspHI (5'TCATGA3') as well
.. ,
as to introduce mutation in the codon encoding the amino
acid residue at position 81 of BstFPS. The introduction
of the cleavage site of BspHI does not change the amino
acid sequence encoded by the BstFPS gene due to
degeneracy of codons. This is used to detect the
substitution-mutated plasmid by means of agarose gel
electrophoresis after digestion with BspHI, since the
introduction of mutation by substitution to the amino
acid residue at position 81 of the BstFPS gene
simultaneously produces a new BspHI cleavage site.
These primer DNA's were subjected to phosphorylation
at 37°C for 30 minutes in the reaction medium shown below
followed by denaturation at 70°C for 10 minutes:
10 pmol/ul primer DNA 2 ~1
10 x kination buffer 1 ~1
10 mM ATP 1 ~1
Hz0 5 ~1
T4 polynucleotide kinase 1 ~1
- in which the 10 x kination buffer is 1000 mM Tris-C1 (pH
8.0), 100 mM MgClz, and 70 mM DTT.
CA 02205892 2000-06-13
- 17 -
Example 3: Introduction of substitution mutation
into the codon corresponding to the amino
acid residue at position 81 of the BstFPS
ene
Using each primer DNA constructed in Example 2,
substitution mutation was introduced into the plasmid
prepared in Example 1 in accordance with the Kunkel
method. Mutan-K*kit commercially available from Takara
Shuzo was used to perform the Kunkel method. The
experimental procedure was as described in the kit
insert. The substitution mutation of the plasmid need
not be conducted by the Kunkel method. For example, the
same result can be obtained by a method using the
polymerase chain reaction (PCR).
Using Escherichia coli CJ236 in the Mutan-K kit as
the host cell, a single strand DNA was obtained in which
the thymine base in plasmid pTV118N-BstFPS was replaced
with deoxyuracil base.
The single stranded DNA thus obtained was used as
the template in a reaction in which a primer DNA for
synthesizing a complementary strand was treated in the
following reaction solution at 65°C for 15 minutes and
then annealed by allowing to stand at 37°C for 15
minutes:
Single strand DNA 0.6 pmol
Annealing buffer solution 1 ~1
Primer DNA solution (Example 2) 1 ~1
Hz0 make to a final volume of 10 ~1
in which the annealing buffer solution is 200 mM Tris-C1
(pH 8.0), 100 mM MgClZ, 500 mM NaCl and 10 mM DTT.
Furthermore, 25 ul of an extention buffer solution,
60 units of Escherichi~a_ co i DNA ligase, and 1 unit of T4
DNA polymerase were added to synthesize a complementary
strand at 25°C for 2 hours.. The extention buffer
solution is 50 mM Tris-C1 (pH 8.0), 60 mM ammonium
acetate, 5 mM MgCl2, 5 mM DTT, 1 mM NAD, and 0.5 mM dNTP.
* Trademark
CA 02205892 1997-07-21
- 18 -
After the reaction is over, 3 ~1 of 0.2 M EDTA (pH
8.0) was added thereto and was subjected to treatment at
65°C for 5 minutes to stop the reaction.
Exa ale 4: Construction of a recombinant having a
crene in which substitution mutation has
been introduced into the codon
corresponding to the amino acid residue
at position-81 of the BstFPS gene
In accordance with Example 3, the DNA solution
constructed was used to transform Escherichia coli DHSoc
by the CaClz method. An alternative method such as the
electroporation gives the same result.
The transformant obtained by the CaClz method was
plated onto the agar plate containing ampicillin, a
selectable marker of transformants, and was incubated
overnight at 37°C.
Among the transformants obtained as above, those
substitution-mutated pTV118N-BstFPS plasmid that has a
BspHI cleavage site in BstFPS coding region was selected.
The nucleotide sequence in the.neighborhood of the codon
corresponding to the amino acid residue at position 81 of
the BstFPS gene of the selected substitution mutated
pTV118N-BstFPS plasmid was determined by the dideoxy
method. As a result, the pTV118N-BstFPS plasmids
containing the following 19 substitution mutated BstFPS
genes were obtained:
Mutation Codon
Y81A GCT
Y81C TGC
Y81D GAC
Y81E GAA
Y81F TTC
Y81G GGT
Y81H CAC
Y81I ATT
Y81K AAG
CA 02205892 1997-07-21
- 19 -
Y81L CTC
Y81M ATG
Y81N ~C
Y81P CCG
Y81Q C
Y81R AGG
Y81S TCG
Y81T ACA
Y81V GTG
Y81W TGG
Y81Y(wild type) TAC
Example 5: Measurement of activity of the mutant
BstFPS
Crude enzyme solutions were prepared as follows from
20 transformants comprising 19 mutant BstFPS genes
.. , .
obtained in Example 4 and one~wild type BstFPS gene.
The transformant cultured overnight in the 2 x LB
medium was centrifuged to harvest cells, and then the
cells were suspended into the buffer for cell
homogenization (50 mM Tris-C1 (pH 8.0), 10 mM
j3-meracptoethanol, 1 mM EDTA). This was homogenized by
sonication and then centrifuged at 4°C at 10,000 r.p.m.
for 10 minutes. The supernatant was treated at 55°C for
minutes to inactivate the activity of prenyl
25 diphosphate synthase derived from Escherichia coli. This
was further centrifuged under the same condition and the
supernatant obtained was used as a crude enzyme extract
in the reaction of 55°C for 15 minutes in the following
reaction solution:
30 [ 1-14C ]-IPP ( 1 C.i/mol ) 25 nmol
Allylic substrate (DMAPP or GPP or FPP) 25 nmol
Tris-C1 (pH8.5) 50 mM
MgClZ 5 mM
NH4C1 50 rru~I
[3-mercaptoethanol 50 mM
Enzyme solution 50 ~.g
CA 02205892 1997-07-21
- 20 -
Hz0 to make 1 ml
After the reaction is over, 3 ml of butanol is added
to extract the reaction product into a butanol layer.
One ml of the butanol layer obtained was added into 3 ml
of liquid scintillator to measure radioactivity by a
scintillation counter. The result is shown in Fig. 1.
Y81P mutant BstFPS has exhibited very little enzymatic
activity, which is inferably due to the fact that only
the proline amino residue is derived from the imino acid,
and therefore it is unable to take the form of a-helix or
(3-sheet structure, thereby significantly changing the
essential higher structure itself of the enzyme.
The solvent is evaporated from remainder of the
butanol layer by purging nitrogen gas thereinto while
heating the layer to concentrate, to 0.5 ml. To the
concentrate were added two ml~of ethanol and one ml of
potato acid phosphatase solution (2 mg/ml potato acid
phosphatase, 0.5 M sodium acetate (pH 4.7)) to effect the
dephosphorylation reaction at 37°C. Subsequently
dephosphorylated reaction product was extracted with 3 ml
of n-pentane. This was concentrated by evaporating the
solvent by purging nitrogen gas thereinto, which was then
analyzed by TLC (reverse phase TLC plate: LKC18
(Whatman), development solvent: acetone/water = 9/1).
The developed dephosphorylated reaction product was
analyzed by the Bio Image Analyzer BAS2000 (Fuji Photo .
Film) to determine the location and the relative
radioactivity. When the amount ratio of all the reaction
products is identical, the ratio of radioactivity becomes
FPP . GGPP . GFPP . HexPP = 2 . 3 . 4 . 5. The result
when DMAPP was used as the allylic substrate is shown in
Fig. 2, when GPP was used as the allylic substrate in
Fig. 3, and when FPP was used as the allylic, substrate in
. Fig. 4.
CA 02205892 1997-07-21
- 21 -
Example 6: Relation of the substitution-mutated
amino acid residue and chain length of
the reaction product
Fig. 1 and Fig. 4 show that when the reaction was
carried out using FPP as the allylic substrate most of
the mutant BstFPSs converts IPP to prenyl diphosphates
having chain length longer than GGPP. At this time, the
substitution mutants in which the side chains of the
amino acids are such small molecules as glycine, alanine,
and serine have a higher activity, whereas the
substitution mutants in which the side chains of the
amino acids are such large wild type molecules as
tyrosine and tryptophan show a lower activity.
Then, the enzymatic activity were plotted against
the molecular weights of the side chains (Fig. 5, Fig. 6,
and Fig. 7) with regard to the~amino acid residue at
position 81. However, the Y81P substitution mutant
enzyme in which enzymatic function was lost is excluded.
As a result, it was clearly shown that when the
molecular weights of the side chains are small the
activity tends to increase (Fig. 7). The tendency was
also observed even when parameters other than the
molecular weight-of the side chain that represents the
size of the amino acid residue was used, such as the
accessible surface area i.e. a parameter of the exposed
surface area of the amino acid residue [C. Chothia (1976)
J. Mol. Biol. 195: 1-14, B. Lee and F.M. Richads (1971)
J. Mol. Biol. 55: 379-400, S. Miller et al. (1987) J.
Mol. Biol. 196: 641) and the like.
There have been very few reports so far indicating
that the chain length of the reaction product was changed
in the study on the mechanism of catalysis of FPP
synthase by the introduction of site specific mutation
without screening such as 'introduction of random
mutation. The fact that the introduction of a single
site-specific mutation enables such a dynamic control of
the chain length of the reaction product as obtained by
CA 02205892 1997-07-21
- 22 -
the present invention was completely unexpected.
From Fig. 5 and 6, it can be seen that when DMAPP
and GPP were used as the allylic substrate there was no
significant relation between the molecular weight of the
substitution-mutated amino acid residue and the enzymatic
activity. This is believed to be caused by the fact that
when FPP is used as the allylic substrate the reaction
specificity of the wild type enzyme is directly reflected
as the enzymatic activity. The specificity that uses
DMAPP and GPP as the allylic substrate is inherently
owned by the wild type enzyme, and therefore the analysis
of tendency is difficult by the parameter of enzymatic
activity alone.
Therefore, the expected value of chain length of the
reaction product, that is the average chain length was
.. , ,
obtained by the following formula:
(the expected value of chain length of a reaction
product) - (ratio of FPP) x 15 + (ratio of GGPP) x 20 +
(ratio of GFPP) x 25 + (ratio of HexPP) x 30
The expected values obtained of the chain lengths of
the reaction products were plotted against the molecular
weights of the side chains of the amino acids at position
81. However, the Y81P substitution mutant enzyme in
which enzymatic function was lost is excluded. It was
found from these figures that the expected values of the
chain length of the reaction product become higher as the
molecular weight of the side chain of the amino acid
residue at position 81 becomes smaller even when the
allylic substrate is DMAPP or GPP.
When a similar plot analysis is made using another
property of the amino acid residue at position 81, such
as Hopp & Woods Scale as a parameter of hydrophobicity
[J. E. Coligan et al. (1995) Current Protocols in Protein
Science, Johen Wiley & Sons, Inc.] no regular tendency is
observed as to the expected value of chain length of the
reaction product or the enzymatic activity when FPP is
used as the allylic substrate. Furthermore, even when
CA 02205892 1997-07-21
- 23 -
parameters such as the ease of taking the cz helix
structure (J. E. Coligan et al. (1995) Current Protocols
in Protein Science, Johen Wiley & Sons, Inc.) or the ease
of taking the ~i-sheet structure [J.E. Coligan et al.
(1995) Current Protocols in Protein Science, Johen Wiley
& Sons, Inc.) are used, no clear relations are observed
with regard to the expected value of the chain length of
the reaction product or the-enzymatic activity when FPP
was used as the allylic substrate. It was clarified for
the first time by the present invention that the factor
responsible for determining the chain length of the
reaction product is the size of the side chain of the
amino acid residue located 5 amino. acid residues upstream
of the aspartic acid-rich domain I (DDXX(XX)D).
CA 02205892 1998-08-25
-24-
SEQUENCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT:
(A) NAME: TOYOTA JIDOSHA KABUSHIKI KAISHA
(B) STREET: 1, TOYOTA-CHO
(C) CITY: TOYOTA-SHI
(D) STATE: AICHI
(E) COUNTRY: JAPAN
(F) POSTAL CODE (ZIP): NONE
(ii) TITLE OF INVENTION: MUTANT PRENYL DIPHOSPHATE SYNTHASE
(iii) NUMBER OF SEQUENCES: 8
(iv) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (EPO)
(v) CURRENT APPLICATION DATA:
APPLICATION NUMBER: CA 2205892
(2) INFORMATION FOR SEQ ID NO: 1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 894 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: double
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: DNA (genomic)
(iii) HYPOTHETICAL: NO
(iv) ANTI-SENSE: NO
(vi) ORIGINAL SOURCE:
(A) ORGANISM: Bacillus stearothermophilus
(ix) FEATURE:
(A) NAME/KEY: CDS
(B) LOCATION:1..894
(xi) SEQUENCE DESCRIPTION: SEQ ID N0: 1:
GTG GCG CAG CTT TCA GTT GAA CAG TTT CTC AAC GAG CAA AAA CAG GCG 48
Met Ala Gln Leu Ser Val Glu Gln Phe Leu Asn Glu Gln Lys Gln Ala
1 5 10 15
CA 02205892 1998-08-25
- 25 -
GTG GAA ACA GCG CTC TCC CGT TAT ATA GAG CGC TTA GAA GGG CCG GCG 96
Val Glu Thr Ala Leu Ser Arg Tyr Ile Glu Arg Leu Glu Gly Pro Ala
20 25 30
AAG CTG AAA AAG GCG ATG GCG TAC TCA TTG GAG GCC GGC GGC AAA CGA 144
Lys Leu Lys Lys Ala Met Ala Tyr Ser Leu Glu Ala Gly Gly Lys Arg
35 40 45
ATC CGT CCG TTG CTG CTT CTG TCC ACC GTT CGG GCG CTC GGC AAA GAC 192
Ile Arg Pro Leu Leu Leu Leu Ser Thr Val Arg Ala Leu Gly Lys Asp
50 55 60
CCG GCG GTC GGA TTG CCC GTC GCC TGC GCG ATT GAA ATG ATC CAT ACG 240
Pro Ala Val Gly Leu Pro Val Ala Cys Ala Ile Glu Met Ile His Thr
65 70 75 80
TAC TCT'TTG ATC CAT GAT GAT TTG CCG AGC ATG GAC AAC GAT GAT TTG 288
Tyr Ser Leu Ile His Asp Asp Leu Pro Ser Met Asp Asn Asp Asp Leu
85 90 95
CGG CGC GGC AAG CCG ACG AAC CAT AAA GTG TTC GGC GAG GCG ATG GCC 336
Arg Arg Gly Lys Pro Thr Asn His Lys Val Phe Gly Glu Ala Met Ala
100 105 110
ATC TTG GCG GGG GAC GGG TTG TTG ACG TAC GCG TTT CAA TTG ATC ACC 384
Ile Leu Ala Gly Asp Gly Leu Leu Thr Tyr Ala Phe Gln Leu Ile Thr
115 120 125
GAA ATC GAC GAT GAG CGC ATC CCT CCT TCC GTC CGG CTT CGG CTC ATC 432
Glu Ile Asp Asp Glu Arg Ile Pro Pro Ser Val Arg Leu Arg Leu Ile
130 135 140
GAA CGG CTG GCG AAA GCG GCC GGT CCG GAA GGG ATG GTC GCC GGT CAG 480
Glu Arg Leu Ala Lys Ala Ala Gly Pro Glu Gly Met Val Ala Gly Gln
145 150 155 160
GCA GCC GAT ATG GAA GGA GAG GGG AAA ACG CTG ACG CTT TCG GAG CTC 528
Ala Ala Asp Met Glu Gly Glu Gly Lys Thr Leu Thr Leu Ser Glu Leu
165 170 175
GAA TAC ATT CAT CGG CAT AAA ACC GGG AAA ATG CTG CAA TAC AGC GTG 576
Glu Tyr Ile His Arg His Lys Thr Gly Lys Met Leu Gln Tyr Ser Val
180 185 190
CAC GCC GGC GCC TTG ATC GGC GGC GCT GAT GCC CGG CAA ACG CGG GAG 624
His Ala Gly Ala Leu Ile Gly Gly Ala Asp Ala Arg Gln Thr Arg Glu
195 200 205
CTT GAC GAA TTC GCC GCC CAT CTA GGC CTT GCC TTT CAA ATT CGC GAT 672
Leu Asp Glu Phe Ala Ala His Leu Gly Leu Ala Phe Gln Ile Arg Asp
210 215 220
CA 02205892 1998-08-25
-26-
GAT ATT CTC GAT ATT GAA GGG GCA GAA GAA AAA ATC GGC AAG CCG GTC 720
Asp Ile Leu Asp Ile Glu Gly Ala Glu Glu Lys Ile Gly Lys Pro Val
225 230 235 240
GGC AGC GAC CAA AGC AAC AAC AAA GCG ACG TAT CCA GCG TTG CTG TCG 768
Gly Ser Asp Gln Ser Asn Asn Lys Ala Thr Tyr Pro Ala Leu Leu Ser
245 250 255
CTT GCC GGC GCG AAG GAA AAG TTG GCG TTC CAT ATC GAG GCG GCG CAG 816
Leu Ala Gly Ala Lys Glu Lys Leu Ala Phe His Ile Glu Ala Ala Gln
260 265 270
CGC CAT TTA CGG AAC GCC GAC GTT GAC GGC GCC GCG CTC GCC TAT ATT 864
Arg His Leu Arg Asn Ala Asp Val Asp Gly Ala Ala Leu Ala Tyr Ile
275 280 285
TGC GAA CTG GTC GCC GCC CGC GAC CAT TAA 894
Cys Glu Leu Val Ala Ala Arg Asp His
290 295
(2) INFORMATION FOR SEQ ID NO: 2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "SYNTHETIC NUCLEIC ACID"
(vii) IMMEDIATE SOURCE:
(B) CLONE: Y81X
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:
GATCCATACG NNNTCTTTGA TTCATGATGA TTTG 34
(2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "SYNTHETIC NUCLEIC ACID"
(vii) IMMEDIATE SOURCE:
(B) CLONE: YS1N
CA 02205892 1998-08-25
-27-
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
GATCCATACG AACTCTTTGA TTCATGATGA TTTG 34
(2) INFORMATION FOR SEQ ID NO: 4:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "SYNTHETIC NUCLEIC ACID"
(vii) IMMEDIATE SOURCE:
(B) CLONE: Y81I
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4:
GATCCATACG ATTTCTTTGA TTCATGATGA TTTG 34
(2) INFORMATION FOR SEQ ID NO: 5:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "SYNTHERTIC NUCLEIC ACID"
(vii) IMMEDIATE SOURCE:
(B) CLONE: Y81M
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:
GATCCATACG ATGTCTTTGA TTCATGATGA TTTG 34
(2) INFORMATION FOR SEQ ID NO: 6:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "SYNTHETIC NUCLEIC ACID"
CA 02205892 1998-08-25
- 27a -
(vii) IMMEDIATE SOURCE:
(B) CLONE: Y81F
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:
GATCCATACG TTCTCTTTGA TTCATGATGA TTTG 34
(2) INFORMATION FOR SEQ ID NO: 7:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "SYNTHETIC NUCLEIC ACID"
(vii) IMMEDIATE SOURCE:
(B) CLONE: Y81P
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7:
GATCCATACG CCGTCTTTGA TTCATGATGA TTTG 34
(2) INFORMATION FOR SEQ ID NO: 8:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 34 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS: single
(D) TOPOLOGY: linear
(ii) MOLECULE TYPE: other nucleic acid
(A) DESCRIPTION: /desc = "SYNTHETIC NUCELID ACID"
(vii) IMMEDIATE SOURCE:
(B) CLONE: Y81V
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:
GATCCATACG GTGTCTTTGA TTCATGATGA TTTG 34
